107 related articles for article (PubMed ID: 12811213)
1. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
Simpson ND; Simpson PW; Ahmed AM; Nguyen MH; Garcia G; Keeffe EB; Ahmed A
J Clin Gastroenterol; 2003 Jul; 37(1):68-71. PubMed ID: 12811213
[TBL] [Abstract][Full Text] [Related]
2. Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.
Su J; Long L; Zou K
Clin Rheumatol; 2018 Dec; 37(12):3201-3214. PubMed ID: 29637482
[TBL] [Abstract][Full Text] [Related]
3. Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors.
Niizuma K; Ogawa Y; Kogure T; Tominaga T
BMC Infect Dis; 2020 Mar; 20(1):230. PubMed ID: 32188424
[TBL] [Abstract][Full Text] [Related]
4. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids.
Arora A; Anand AC; Kumar A; Singh SP; Aggarwal R; Dhiman RK; Aggarwal S; Alam S; Bhaumik P; Dixit VK; Goel A; Goswami B; Kumar A; Kumar M; Madan K; Murugan N; Nagral A; Puri AS; Rao PN; Saraf N; Saraswat VA; Sehgal S; Sharma P; Shenoy KT; Wadhawan M;
J Clin Exp Hepatol; 2018 Dec; 8(4):403-431. PubMed ID: 30568345
[TBL] [Abstract][Full Text] [Related]
5. Low level of hepatitis B virus screening among patients receiving chemotherapy.
Wi CI; Loo NM; Larson JJ; Moynihan TJ; Madde NR; Grendahl DC; Alberts SR; Kim WR
Clin Gastroenterol Hepatol; 2015 May; 13(5):970-5; quiz e51. PubMed ID: 25460017
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.
Lee RS; Bell CM; Singh JM; Hicks LK
J Oncol Pract; 2012 Nov; 8(6):325-8, 1 p following 328. PubMed ID: 23598840
[TBL] [Abstract][Full Text] [Related]
7. Case report: Recombinant human type II tumour necrosis factor receptor-antibody fusion protein induced occult hepatitis B virus reactivation leading to liver failure.
Qin Y; Zhou W; Zhou X; Li H
J Int Med Res; 2024 May; 52(5):3000605241252580. PubMed ID: 38760056
[TBL] [Abstract][Full Text] [Related]
8. Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy.
Zou X; Guo L; Gu Y; Yang Z; Huang P; Liu T; Zhao J; Wu G
J Cancer; 2020; 11(12):3559-3566. PubMed ID: 32284752
[No Abstract] [Full Text] [Related]
9. RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.
Wang J; Jia J; Chen R; Ding S; Xu Q; Zhang T; Chen X; Liu S; Lu F
Cancer Med; 2018 May; 7(5):2021-2033. PubMed ID: 29601674
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma.
Chhibar P; Zhu Z; Cheedella NK; Chaudhry R; Wang JC
Am J Case Rep; 2016 Jun; 17():371-4. PubMed ID: 27246626
[TBL] [Abstract][Full Text] [Related]
11. Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis.
Colapietro F; Pugliese N; Voza A; Aghemo A; De Nicola S
World J Gastroenterol; 2024 Mar; 30(9):1253-1256. PubMed ID: 38577192
[TBL] [Abstract][Full Text] [Related]
12. Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapy.
Nakashima T; Kusumoto S; Ishida T; Kato C; Hagiwara S; Narita T; Masaki A; Ito A; Ri M; Komatsu H; Inagaki H; Tanaka Y; Iida S
Hepatol Res; 2024 May; ():. PubMed ID: 38770705
[TBL] [Abstract][Full Text] [Related]
13. A Case of Hepatitis B Virus Reactivation Triggered by Acute Epstein-Barr Virus Infection.
Beran A; Mhanna M; Haghbin H; Sample JW; Burlen J
Cureus; 2021 Oct; 13(10):e18676. PubMed ID: 34786256
[TBL] [Abstract][Full Text] [Related]
14. Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection.
Pockros PJ
Gastroenterol Hepatol (N Y); 2017 Sep; 13(9):536-540. PubMed ID: 29038644
[TBL] [Abstract][Full Text] [Related]
15. Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma.
Torres HA; Mustafayev K; Nastoupil LJ; Shelburne SA
Lancet; 2024 Apr; 403(10434):1372-1373. PubMed ID: 38582568
[No Abstract] [Full Text] [Related]
16. Hepatitis B virus reactivation in patients treated with monoclonal antibodies.
De Pauli S; Grando M; Miotti G; Zeppieri M
World J Virol; 2024 Mar; 13(1):88487. PubMed ID: 38616853
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-induced Immune Dysfunction and Activation of Transcription Factor AP-1 Facilitate Hepatitis B Virus Replication.
Chen S; Li B; Luo W; Rehman AU; He M; Yang Q; Wang S; Guo J; Chen L; Li X
J Clin Transl Hepatol; 2024 May; 12(5):457-468. PubMed ID: 38779518
[TBL] [Abstract][Full Text] [Related]
18. [The Department of Pharmacy at Fukuoka University Hospital's Role in Preventing Hepatitis B Virus Reactivation in Patients Taking Oral Anticancer Drugs].
Fukuyama K; Kakimoto H; Nagasato A; Okurano M; Eguchi Y; Ikeuchi T; Kaneshige S; Ogata K; Kamimura H
Gan To Kagaku Ryoho; 2023 Aug; 50(8):885-889. PubMed ID: 37608414
[TBL] [Abstract][Full Text] [Related]
19. Upadacitinib-Induced Hepatitis B Reactivation Leading to Liver Transplant.
Khan SA; Zahid R; Amir M
ACG Case Rep J; 2024 Apr; 11(4):e01327. PubMed ID: 38586821
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
